$776 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 62 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 27.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Sell | AMICUS THERAPEUTICS | $36,386,000 | +3.7% | 2,412,870 | -30.7% | 4.69% | +22.2% |
| PFE | Sell | PFIZER INC | $34,189,000 | -27.6% | 957,673 | -31.9% | 4.40% | -14.7% |
| NVS | Sell | NOVARTIS AGspns adr | $32,949,000 | -29.4% | 383,796 | -31.4% | 4.24% | -16.9% |
| ACAD | Sell | ACADIA PHARMACEUTICALS | $30,980,000 | +1.1% | 822,392 | -25.2% | 3.99% | +19.1% |
| JNJ | Sell | JOHNSON & JOHNSON | $30,598,000 | -34.7% | 235,349 | -33.5% | 3.94% | -23.1% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS | $27,362,000 | +15.4% | 506,414 | +20.0% | 3.52% | +35.9% |
| TDOC | Buy | TELADOC INC | $24,312,000 | +29.0% | 733,379 | +35.0% | 3.13% | +52.0% |
| LOXO | Buy | LOXO ONCOLOGY INC | $22,590,000 | +27.0% | 245,226 | +10.6% | 2.91% | +49.6% |
| XLRN | Buy | ACCELERON PHARMA | $22,577,000 | +22.9% | 604,957 | +0.1% | 2.91% | +44.7% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $22,189,000 | -22.0% | 238,413 | -23.9% | 2.86% | -8.2% |
| MDT | Sell | MEDTRONIC PLC | $21,866,000 | -38.2% | 281,160 | -29.4% | 2.82% | -27.1% |
| ABMD | Sell | ABIOMED INC | $21,694,000 | -34.0% | 128,671 | -43.9% | 2.79% | -22.2% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL | $20,920,000 | +19.1% | 601,500 | +2.0% | 2.70% | +40.3% |
| MRK | Sell | MERCK & CO INC | $20,828,000 | -55.5% | 325,280 | -55.4% | 2.68% | -47.5% |
| CLVS | Buy | CLOVIS ONCOLOGY | $20,740,000 | +594.3% | 251,699 | +689.0% | 2.67% | +717.1% |
| TSRO | New | TESARO INC | $19,339,000 | – | 149,799 | +100.0% | 2.49% | – |
| UNH | New | UNITEDHEALTH GRP INC | $19,233,000 | – | 98,205 | +100.0% | 2.48% | – |
| GILD | New | GILEAD SCIENCES INC | $19,032,000 | – | 234,900 | +100.0% | 2.45% | – |
| KTWO | Sell | K2M GROUP HOLDINGS | $19,019,000 | -24.1% | 896,714 | -12.8% | 2.45% | -10.6% |
| CELG | Sell | CELGENE CORP | $18,801,000 | -38.1% | 128,932 | -44.8% | 2.42% | -27.0% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL | $18,352,000 | -18.9% | 1,749,457 | -3.3% | 2.36% | -4.4% |
| AERI | Sell | AERIE PHARMACEUTICALS | $18,147,000 | -14.2% | 373,396 | -7.3% | 2.34% | +1.0% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS | $16,572,000 | +33.8% | 533,708 | +17.9% | 2.14% | +57.7% |
| ACHC | Sell | ACADIA HEALTHCARE | $15,737,000 | -47.2% | 329,510 | -45.4% | 2.03% | -37.8% |
| MOH | New | MOLINA HEALTHCARE | $15,152,000 | – | 220,359 | +100.0% | 1.95% | – |
| REGN | Sell | REGENERON PHARMACEUTICALS | $14,718,000 | -52.4% | 32,917 | -47.7% | 1.90% | -43.9% |
| EW | Sell | EDWARDS LIFESCIENCE | $14,492,000 | -23.6% | 132,580 | -17.3% | 1.87% | -10.0% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES | $14,254,000 | +29.8% | 232,602 | -2.6% | 1.84% | +52.9% |
| PRTA | Buy | PROTHENA CORP PLC | $12,689,000 | +55.2% | 195,909 | +29.7% | 1.64% | +82.9% |
| EVH | Buy | EVOLENT HEALTH INC | $11,618,000 | -14.0% | 652,680 | +22.5% | 1.50% | +1.4% |
| ONCE | Buy | SPARK THERAPEUTICS | $10,396,000 | +71.8% | 116,599 | +15.1% | 1.34% | +102.3% |
| WMGI | Buy | WRIGHT MED GROUP N V | $9,667,000 | -5.9% | 373,672 | +0.0% | 1.24% | +10.9% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES | $9,608,000 | +22.1% | 185,200 | +0.0% | 1.24% | +44.0% |
| CI | Buy | CIGNA CORP | $8,527,000 | +228.5% | 45,615 | +194.1% | 1.10% | +286.6% |
| NUVA | Sell | NUVASIVE INC | $7,337,000 | -75.7% | 132,290 | -66.4% | 0.94% | -71.4% |
| ZLAB | New | ZAI LAB LTDadr | $7,171,000 | – | 265,600 | +100.0% | 0.92% | – |
| IART | Sell | INTEGRA LIFESCIENCE | $7,106,000 | -46.6% | 140,778 | -42.3% | 0.92% | -37.1% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS | $6,891,000 | +36.2% | 372,499 | +24.4% | 0.89% | +60.6% |
| MASI | Sell | MASIMO CORP | $6,302,000 | -5.7% | 72,800 | -0.7% | 0.81% | +11.1% |
| Sell | NEURODERM LTD | $5,748,000 | -45.1% | 147,756 | -57.8% | 0.74% | -35.4% | |
| EXAS | New | EXACT SCIENCES CORP | $5,539,000 | – | 117,550 | +100.0% | 0.71% | – |
| VRTX | New | VERTEX PHARMACEUTICL | $5,169,000 | – | 34,000 | +100.0% | 0.67% | – |
| EVHC | Sell | ENVISION HEALTHCARE | $5,106,000 | -38.8% | 113,600 | -14.7% | 0.66% | -27.9% |
| RARX | Buy | RA PHARMACEUTICALS | $4,060,000 | +21.2% | 278,082 | +55.6% | 0.52% | +42.9% |
| INCY | Buy | INCYTE CORPORATION | $3,939,000 | +43.2% | 33,745 | +54.5% | 0.51% | +68.4% |
| PTCT | Buy | PTC THERAPEUTICS I | $3,412,000 | +206.6% | 170,535 | +180.8% | 0.44% | +260.7% |
| ALBO | Sell | ALBIREO PHARMA INC | $3,311,000 | -14.8% | 158,027 | -16.3% | 0.43% | +0.5% |
| AGIO | Sell | AGIOS PHARMACEUTICALS | $3,191,000 | -49.8% | 47,799 | -61.3% | 0.41% | -40.9% |
| New | INTEC PHARMA LTD JER | $3,177,000 | – | 355,000 | +100.0% | 0.41% | – | |
| SRPT | Buy | SAREPTA THERAPEUTICS | $3,134,000 | +222.8% | 69,099 | +139.9% | 0.40% | +281.1% |
| ARAY | Buy | ACCURAY INC | $2,750,000 | -1.6% | 687,547 | +16.9% | 0.35% | +15.7% |
| NXTM | Sell | NXSTAGE MEDICAL | $2,721,000 | -69.0% | 98,579 | -71.8% | 0.35% | -63.4% |
| DBVT | Sell | DBV TECHNOLOGIESspns adr | $2,241,000 | -65.0% | 52,799 | -70.5% | 0.29% | -58.7% |
| SBPH | Buy | SPRING BK PHARMACEUTICALS | $2,078,000 | +36.4% | 123,383 | +9.7% | 0.27% | +60.5% |
| INSM | Sell | INSMED INC | $1,947,000 | -22.2% | 62,399 | -57.2% | 0.25% | -8.4% |
| ILMN | Sell | ILLUMINA INC | $1,863,000 | -36.3% | 9,350 | -44.5% | 0.24% | -25.0% |
| OBSV | OBSEVA SA | $1,732,000 | -4.8% | 212,831 | 0.0% | 0.22% | +12.1% | |
| RDY | Buy | DR REDDYS LABS LTDadr | $1,634,000 | +103.5% | 45,796 | +140.2% | 0.21% | +138.6% |
| Buy | TRILLIUM THERAPEUTCS | $1,206,000 | +49.6% | 234,248 | +27.8% | 0.16% | +76.1% | |
| TGTX | Buy | TG THERAPEUTICS | $1,189,000 | +45.5% | 100,366 | +23.5% | 0.15% | +71.9% |
| CMTA | New | CLEMENTIA PHARMACEUT | $512,000 | – | 30,313 | +100.0% | 0.07% | – |
| SRRA | SIERRA ONCOLOGY INC | $313,000 | +32.6% | 201,660 | 0.0% | 0.04% | +53.8% | |
| SAGE | Exit | SAGE THERAPEUTICS | $0 | – | -12,199 | -100.0% | -0.11% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP | $0 | – | -168,300 | -100.0% | -0.18% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -104,757 | -100.0% | -0.20% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -820,699 | -100.0% | -1.00% | – |
| ISRG | Exit | INTUITIVE SURGIC INC | $0 | – | -16,467 | -100.0% | -1.68% | – |
| MYL | Exit | MYLAN N V | $0 | – | -495,804 | -100.0% | -2.10% | – |
| TEVA | Exit | TEVA PHARMACEUTICALsp adr | $0 | – | -602,279 | -100.0% | -2.19% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -333,341 | -100.0% | -2.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.